Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cimetidine plus low-dose meglumine antimoniate versus standard-dose meglumine antimoniate for Syrian cutaneous leishmaniasis
IRCT2013123116016N1Phase 3Completed
- Sponsor
- University of Aleppo
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of cimetidine and meglumine antimoniate in cutaneous leishmaniasis (CL) (2 arms), sponsored by University of Aleppo. Started Dec 2009; status: completed.
02
Drugs
cimetidinemeglumine antimoniate
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT2013123116016N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013123116016N1.